ACETNasdaqPharmaceutical PreparationsFiscal year ends December 26
Adicet Bio, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$4.53−0.04 (-0.88%)
Close on Oct 19, 2026
- Market cap
- $48.68M
- P/E (TTM)
- –
- Dividend yield
- –
Adicet Bio statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Adicet Bio | Industry median |
|---|---|---|
| Market Cap | $42.41M | $166.30M |
| Enterprise Value | $9.28M | $88.19M |
| PB Ratio | 0.35 | 2.03 |
| P/TBV Ratio | 0.35 | 2.29 |
Income (trailing twelve months)
| Measure | Adicet Bio | Industry median |
|---|---|---|
| Operating Income | -$103.71M | -$21.40M |
| Pretax Income | -$98.83M | -$14.34M |
| Net Income | -$98.97M | -$22.46M |
| EBITDA | -$98.09M | -$16.91M |
| EPS (Diluted) | -$11.43 | -$0.83 |
Returns
| Measure | Adicet Bio | Industry median |
|---|---|---|
| Return on Equity (ROE) | -78.1% | -53.2% |
| Return on Assets (ROA) | -63.6% | -40.9% |
| Return on Invested Capital (ROIC) | -88.3% | -32.4% |
| Return on Capital Employed (ROCE) | -79.7% | -38.1% |
Balance sheet
| Measure | Adicet Bio | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $33.13M | $61.43M |
| Net Cash (Debt) | $33.13M | $15.35M |
| Net Cash Per Share | $3.54 | $0.66 |
| Equity (Book Value) | $120.14M | $49.09M |
| Book Value Per Share | $12.83 | $1.37 |
| Tangible Book Value | $120.14M | $23.52M |
| Working Capital | $102.76M | $76.81M |
Financial position
| Measure | Adicet Bio | Industry median |
|---|---|---|
| Current Ratio | 6.71 | 3.34 |
| Quick Ratio | 1.84 | 2.44 |
| Interest Coverage | -1280.36 | -6.26 |
Cash flow (trailing twelve months)
| Measure | Adicet Bio | Industry median |
|---|---|---|
| Operating Cash Flow | -$84.53M | -$12.35M |
| Capital Expenditures | -$438.00K | -$1.08M |
| Free Cash Flow | -$84.97M | -$20.22M |
| FCF Per Share | -$9.08 | -$0.42 |
Efficiency
| Measure | Adicet Bio | Industry median |
|---|---|---|
| Profits Per Employee | -$970.33K | -$703.34K |
| Employee Count | 102 | 74 |
Dividends and yields
| Measure | Adicet Bio | Industry median |
|---|---|---|
| Earnings Yield | -233.4% | -23.3% |
| FCF Yield | -200.4% | -8.72% |
Shares
| Measure | Adicet Bio | Industry median |
|---|---|---|
| Shares Outstanding | 9,361,490 | 58,127,000 |
| Shares Change (YoY) | 65.5% | 10.9% |
| Shares Change (QoQ) | -2.46% | 0.54% |
| Float | 715,571 | 49,136,700 |
| Shares Held by Insiders | 92.4% | 11.6% |
| Shares Held by Institutions | 65.3% | 59.4% |
Taxes
| Measure | Adicet Bio | Industry median |
|---|---|---|
| Income Tax | $143.00K | $79.87K |
Scores
| Measure | Adicet Bio | Industry median |
|---|---|---|
| Altman Z-Score | -6.77 | -0.22 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Adicet Bio's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.